Marsh & McLennan Companies (NYSE:MRSH) Price Target Cut to $206.00 by Analysts at JPMorgan Chase & Co.

Marsh & McLennan Companies (NYSE:MRSH) had its price objective decreased by JPMorgan Chase & Co. from $226.00 to $206.00 in a report issued on Thursday morning,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the financial services provider’s stock.

A number of other research analysts have also weighed in on MRSH. Royal Bank Of Canada restated a “sector perform” rating and set a $200.00 price objective on shares of Marsh & McLennan Companies in a research report on Friday, January 30th. Cantor Fitzgerald raised their price objective on Marsh & McLennan Companies from $208.00 to $212.00 and gave the company an “overweight” rating in a research report on Monday, February 2nd. Barclays cut their price objective on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research report on Wednesday. Wells Fargo & Company cut their price objective on Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating for the company in a research report on Thursday. Finally, Mizuho restated a “neutral” rating and set a $199.00 price objective (down from $213.00) on shares of Marsh & McLennan Companies in a research report on Friday, February 27th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Marsh & McLennan Companies currently has an average rating of “Hold” and a consensus target price of $208.38.

Marsh & McLennan Companies Stock Down 1.5%

NYSE:MRSH traded down $2.69 on Thursday, reaching $173.12. 1,495,189 shares of the company’s stock traded hands, compared to its average volume of 3,070,453. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.10 and a current ratio of 1.10. The stock’s 50-day moving average is $174.39. The stock has a market capitalization of $83.81 billion, a price-to-earnings ratio of 20.54, a PEG ratio of 2.38 and a beta of 0.75. Marsh & McLennan Companies has a 12 month low of $164.89 and a 12 month high of $239.34.

Marsh & McLennan Companies (NYSE:MRSH) last posted its quarterly earnings results on Thursday, January 29th. The financial services provider reported $2.12 EPS for the quarter, beating analysts’ consensus estimates of $1.97 by $0.15. The business had revenue of $6.60 billion for the quarter, compared to analysts’ expectations of $6.52 billion. Marsh & McLennan Companies had a return on equity of 31.60% and a net margin of 15.42%.The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period last year, the firm earned $1.87 earnings per share. On average, equities analysts anticipate that Marsh & McLennan Companies will post 9.61 earnings per share for the current year.

Marsh & McLennan Companies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Thursday, April 9th will be given a $0.90 dividend. The ex-dividend date is Thursday, April 9th. This represents a $3.60 annualized dividend and a yield of 2.1%. Marsh & McLennan Companies’s dividend payout ratio (DPR) is currently 42.70%.

Insider Buying and Selling

In related news, CEO John Q. Doyle sold 16,655 shares of Marsh & McLennan Companies stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total value of $3,052,861.50. Following the completion of the transaction, the chief executive officer owned 116,811 shares in the company, valued at approximately $21,411,456.30. This trade represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.35% of the company’s stock.

Institutional Trading of Marsh & McLennan Companies

Several institutional investors have recently added to or reduced their stakes in MRSH. Numerai GP LLC increased its holdings in shares of Marsh & McLennan Companies by 966.2% during the 3rd quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock worth $7,501,000 after buying an additional 33,729 shares during the last quarter. Rockland Trust Co. increased its holdings in shares of Marsh & McLennan Companies by 801.6% during the 3rd quarter. Rockland Trust Co. now owns 12,073 shares of the financial services provider’s stock worth $2,433,000 after buying an additional 10,734 shares during the last quarter. Barclays PLC increased its holdings in shares of Marsh & McLennan Companies by 41.7% during the 3rd quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock worth $443,844,000 after buying an additional 647,987 shares during the last quarter. Navera Investment Management Ltd. increased its holdings in shares of Marsh & McLennan Companies by 7.0% during the 3rd quarter. Navera Investment Management Ltd. now owns 1,623,960 shares of the financial services provider’s stock worth $327,303,000 after buying an additional 105,954 shares during the last quarter. Finally, Bridges Investment Management Inc. increased its holdings in shares of Marsh & McLennan Companies by 4.4% during the 3rd quarter. Bridges Investment Management Inc. now owns 76,196 shares of the financial services provider’s stock worth $15,356,000 after buying an additional 3,177 shares during the last quarter. Institutional investors own 87.99% of the company’s stock.

Marsh & McLennan Companies News Roundup

Here are the key news stories impacting Marsh & McLennan Companies this week:

• Positive Sentiment: Barclays reaffirmed an Overweight/Buy view on MRSH, maintaining a constructive stance that supports upside potential. Article Title
• Positive Sentiment: Zacks highlights that MRSH appears positioned for an earnings beat — analysts point to the right mix of revenue and margin drivers ahead of results, which could buoy the stock if confirmed. Article Title
• Positive Sentiment: Marsh closed a small acquisition (Seitz Insurance Agency) to expand its Montana footprint and middle?market distribution — a strategic tuck?in that can drive cross?sell and local revenue growth over time. Article Title
• Neutral Sentiment: Morgan Stanley reiterated a Hold on MRSH, which is unlikely to shift investor conviction materially but contributes to mixed analyst sentiment. Article Title
• Neutral Sentiment: Barclays trimmed its price target slightly (from $209 to $206) but kept an Overweight rating — a modest adjustment that still implies meaningful upside. Article Title
• Neutral Sentiment: Options activity suggests traders are positioning for a sizable move in MRSH, indicating higher near?term volatility even if direction is uncertain. Article Title
• Neutral Sentiment: Consensus brokerage coverage remains clustered around Hold, keeping analyst guidance mixed overall. Article Title
• Negative Sentiment: Wells Fargo cut its price target sharply (from $203 to $178) and set an Equal Weight rating — the downgrade is the primary near?term negative driver pressuring the stock today. Article Title

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.